BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 20116809)

  • 41. Sleep in Wilson's disease: a polysomnography-based study.
    Netto AB; Sinha S; Taly AB; Panda S; Rao S
    Neurol India; 2010; 58(6):933-8. PubMed ID: 21150062
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cognitive profile and structural findings in Wilson's disease: a neuropsychological and MRI-based study.
    Hegde S; Sinha S; Rao SL; Taly AB; Vasudev MK
    Neurol India; 2010; 58(5):708-13. PubMed ID: 21045492
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Late-onset epilepsy in children with acute febrile encephalopathy with prolonged convulsions: A clinical and encephalographic study.
    Saito T; Saito Y; Sugai K; Nakagawa E; Komaki H; Okazaki T; Ishido Y; Kaneko Y; Kaido T; Takahashi A; Ohtsuki T; Sakuma H; Sasaki M
    Brain Dev; 2013 Jun; 35(6):531-9. PubMed ID: 22982002
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Longitudinal brain volumes in children with intractable partial seizures.
    Widjaja E; Yeung R; Geibprasert S; Mahmoodabadi SZ; Snead OC; Smith ML
    Pediatr Neurol; 2010 May; 42(5):315-9. PubMed ID: 20399383
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Partial status epilepticus induced by hypocupremia in a patient with Wilson's disease.
    Benbir G; Gunduz A; Ertan S; Ozkara C
    Seizure; 2010 Nov; 19(9):602-4. PubMed ID: 20732822
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Epilepsy and EEG paroxysmal abnormalities in autism spectrum disorders.
    Parmeggiani A; Barcia G; Posar A; Raimondi E; Santucci M; Scaduto MC
    Brain Dev; 2010 Oct; 32(9):783-9. PubMed ID: 20691552
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Widespread cerebral cortical mineralization in Wilson's disease detected by susceptibility-weighted imaging.
    Lee JH; Yang TI; Cho M; Yoon KT; Baik SK; Han YH
    J Neurol Sci; 2012 Feb; 313(1-2):54-6. PubMed ID: 22014607
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Epilepsy after neuroimaging normalization in a woman with tacrolimus-related posterior reversible encephalopathy syndrome.
    Baldini M; Bartolini E; Gori S; Bonanni E; Cosottini M; Iudice A; Murri L
    Epilepsy Behav; 2010 Apr; 17(4):558-60. PubMed ID: 20171145
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Epilepsy and Behçet's disease: cortical and hippocampal involvement in Brazilian patients.
    Dutra LA; Braga-Neto P; Pedroso JL; Guedes Bde V; de Souza LT; Gonçalves CR; de Souza AW; Gabbai AA; Barsottini OG
    J Neurol Sci; 2011 Oct; 309(1-2):1-4. PubMed ID: 21855087
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Electroencephalographic and seizure manifestations of pyridoxal 5'-phosphate-dependent epilepsy.
    Veerapandiyan A; Winchester SA; Gallentine WB; Smith EC; Kansagra S; Hyland K; Mikati MA
    Epilepsy Behav; 2011 Mar; 20(3):494-501. PubMed ID: 21292558
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Unusual epileptic deterioration and extensive white matter lesion during treatment in Wilson's disease.
    Kim YE; Yun JY; Yang HJ; Kim HJ; Jeon BS
    BMC Neurol; 2013 Sep; 13():127. PubMed ID: 24067156
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Wilson's disease: cranial MRI observations and clinical correlation.
    Sinha S; Taly AB; Ravishankar S; Prashanth LK; Venugopal KS; Arunodaya GR; Vasudev MK; Swamy HS
    Neuroradiology; 2006 Sep; 48(9):613-21. PubMed ID: 16752136
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Frequent association of autism spectrum disorder in patients with childhood onset epilepsy.
    Matsuo M; Maeda T; Sasaki K; Ishii K; Hamasaki Y
    Brain Dev; 2010 Oct; 32(9):759-63. PubMed ID: 20542395
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Long-term outcome in pyridoxine-dependent epilepsy.
    Bok LA; Halbertsma FJ; Houterman S; Wevers RA; Vreeswijk C; Jakobs C; Struys E; Van Der Hoeven JH; Sival DA; Willemsen MA
    Dev Med Child Neurol; 2012 Sep; 54(9):849-54. PubMed ID: 22804844
    [TBL] [Abstract][Full Text] [Related]  

  • 55. EEG spectral analysis and topographic mapping in Wilson's disease.
    Chu NS; Chu CC; Tu SC; Huang CC
    J Neurol Sci; 1991 Nov; 106(1):1-9. PubMed ID: 1779232
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Retrospective audit of postictal generalized EEG suppression in telemetry.
    Semmelroch M; Elwes RD; Lozsadi DA; Nashef L
    Epilepsia; 2012 Feb; 53(2):e21-4. PubMed ID: 22050242
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Epileptic seizures in neurofibromatosis type 1 are related to intracranial tumors but not to neurofibromatosis bright objects.
    Hsieh HY; Fung HC; Wang CJ; Chin SC; Wu T
    Seizure; 2011 Oct; 20(8):606-11. PubMed ID: 21621428
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Exploring cortical atrophy and its clinical and biochemical correlates in Wilson's disease using voxel based morphometry.
    Stezin A; George L; Jhunjhunwala K; Lenka A; Saini J; Netravathi M; Yadav R; Pal PK
    Parkinsonism Relat Disord; 2016 Sep; 30():52-7. PubMed ID: 27372240
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Homogeneous magnetic resonance imaging of brain abnormalities in bipolar spectrum disorders comorbid with Wilson's disease.
    Carta MG; Saba L; Moro MF; Demelia E; Sorbello O; Pintus M; Pintus E; Simavorian T; Akiskal H; Demelia L
    Gen Hosp Psychiatry; 2015; 37(2):134-8. PubMed ID: 25772945
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Temporal changes in brain MRI findings in Rasmussen syndrome.
    Yamazaki E; Takahashi Y; Akasaka N; Fujiwara T; Inoue Y
    Epileptic Disord; 2011 Sep; 13(3):229-39. PubMed ID: 21926050
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.